The $26B Blind Spot: Why Hospitals Are Failing to Stop Pressure Injuries
Hospital-acquired pressure injuries claim roughly 60,000 U.S. lives and cost an estimated $26.8 billion each year. About 2.5 million patients develop these injuries, with up to one in four ICU patients affected. While electronic health records and predictive analytics flag risk, the core preventive actions—repositioning and mobility—often falter due to staffing constraints and workflow gaps. Industry leaders argue that operational ownership, not just clinical knowledge, is essential to close the safety gap.
AI Deployment May Actually Increase Healthcare Costs
A new Peterson Health Technology Institute report finds that while AI eases administrative tasks for hospitals, it often drives up costs. The technology accelerates the volume of billing, prior‑authorization and claim‑processing transactions without addressing deep‑seated inefficiencies. More complete documentation and...
Lilly to Acquire Ajax Therapeutics
Eli Lilly announced a definitive agreement to acquire Ajax Therapeutics for up to $2.3 billion in cash. Ajax’s lead candidate, AJ1-11095, is a first‑in‑class Type II JAK2 inhibitor currently in a Phase 1 study (AJX‑101) for myelofibrosis patients who have failed Type I JAK2...
University of Southampton and UCB to Develop Digital Antibodies with AI
The University of Southampton and biopharma firm UCB have launched the Digital Antibody Research Collaboration (DARC), a three‑year AI‑driven platform for in‑silico therapeutic antibody design. DARC aims to compress the typical ten‑to‑twelve‑year development timeline by automating molecule modeling, testing and...
What the Parties Promise Welsh Voters on the NHS, Schools, Childcare and Tax
The six parties vying for Wales’s expanded 96‑seat Senedd present starkly different NHS, education, childcare and tax roadmaps, yet all omit concrete financing. Labour promises £4 bn (≈$5 bn) for new hospitals and pledges no income‑tax rise, while Plaid Cymru offers 24‑hour...
This Dangerous Pregnancy Complication Is Common. A New Treatment Might Help
A novel blood‑filter that removes excess soluble Flt‑1 reduced the protein by roughly 17% in a pilot study of 16 women with early‑onset preeclampsia. The intervention modestly lowered blood pressure and proteinuria, allowing pregnancies to extend a median of 10...
5 Questions About Private 5G for Healthcare Organizations
Private 5G is emerging as a viable alternative to campus Wi‑Fi for hospitals, offering higher device density, lower latency, and deterministic performance. The technology leverages dedicated spectrum, either purchased, leased, or accessed via the FCC’s free General Authorized Access band,...
This Hidden Kind of Stress May Be Damaging Your Memory as You Age
Rutgers Health researchers found that internalized stress—feelings of hopelessness and the tendency to bottle up stress—significantly accelerates memory loss in Chinese Americans over 60. The analysis used data from the Population Study of Chinese Elderly (PINE), tracking more than 1,500...
ESCMID Global 2026: Pritelivir Excels in Immunocompromised Refractory HSV Patients
Aicuris presented Phase III data for its oral helicase‑primase inhibitor pritelivir at ESCMID Global 2026. In the PRIOH‑1 trial of 101 immunocompromised adults with acyclovir‑refractory HSV, pritelivir achieved significantly higher lesion‑healing rates than investigator‑chosen IV or topical therapies. The drug also...
Ambient AI Tools Improve the Patient-Clinician Connection
Ambient AI, championed by Abridge, captures entire patient visits and drafts clinical notes in real time, allowing clinicians to stay fully present during encounters. Matt Troup, Abridge’s clinical strategy principal, says the technology eases cognitive burden and helps patients feel...
The Bad Ad Program
The FDA’s Bad Ad Program, run by the Office of Prescription Drug Promotion, educates clinicians on spotting false or misleading prescription‑drug advertising and provides a streamlined way to report violations. It targets a broad audience of physicians, nurses, pharmacists and...
Partnership for Clinical Decision Support Moves AI to Next Level
AI-driven clinical decision support has taken a leap forward as Abridge announced a partnership with the New England Journal of Medicine and JAMA. The collaboration will embed peer-reviewed articles and guideline evidence directly into Abridge’s platform, linking them with real-time...
Reconsider when Children Start Playing Tackle Football
Recent research confirms that tackle football is the leading cause of youth sports‑related traumatic brain injuries, with middle‑school players experiencing 2.6‑2.9 concussions per 1,000 athletic exposures. Data from 2010‑2016 show 283,000 children under 18 sought emergency care for sports TBIs,...
Collaborative Develops AI Vendor Disclosure Framework
The Health AI Partnership (HAIP) has published an AI Vendor Disclosure Framework in NEJM AI, offering a free, publicly‑available tool for health‑system leaders evaluating AI solutions. The framework outlines five core domains—system capabilities, performance, data stewardship, integration requirements, and lifecycle management—to...
MFN Changing the Rules of the Game for the Nordic Countries
GlobalData’s Price Intelligence analysis links the U.S. Most Favored Nation (MFN) policy to a 35% decline in pharmaceutical product launches across Europe within ten months of its introduction. In the Nordics, oncology drugs are priced roughly 5% below the European...
Missouri Analytical Laboratories Inc - 615319 - 10/09/2024
The U.S. Food and Drug Administration issued a closeout letter to Missouri Analytical Laboratories Inc., confirming that the company’s corrective actions have addressed the violations cited in a 2021 warning letter. The FDA noted that while the immediate issues appear...
New AAD Leaders Aim to Fix ‘Broken’ Access to Care, Serve Next Generation of Dermatologists
Murad Alam assumed the presidency of the American Academy of Dermatology (AAD) on April 27, 2026, with a focus on fixing the broken access‑to‑care model that hampers dermatology practices. He outlined a strategy to rally AAD members, lobby Congress, and secure resources...
Lilly to Buy Startup Ajax in Bid for a Better JAK Drug
Eli Lilly announced it will acquire New York‑based biotech Ajax Therapeutics for up to $2.3 billion. The deal centers on Ajax’s experimental JAK inhibitor AJ1‑11095, which binds an inactive JAK2 conformation to overcome resistance seen with existing therapies for myelofibrosis and...
FDA Grand Rounds – Anti-Biofilm Technologies for Enhancing the Safety of Medical Device Surfaces - 05/29/2025
On May 29, 2025, the FDA hosted a Grand Rounds webcast on anti‑biofilm technologies for medical device surfaces, presented by Dr. Jayaleka J. Amarasinghe, a microbiologist at the agency’s Winchester Engineering and Analytical Center. The session highlighted two emerging strategies...
ACA Subsidy Lapse Cost HCA Healthcare $150M in Q1
HCA Healthcare disclosed that the expiration of enhanced Affordable Care Act subsidies cost the company about $150 million in the first quarter, aligning with its forecast of a $600‑$900 million annual hit. ACA‑covered admissions fell roughly 15% year‑over‑year while admissions for uninsured...
A Single Dose of Psilocybin Outperforms Nicotine Patches for Quitting Smoking
A Johns Hopkins pilot trial found that a single, weight‑adjusted dose of psilocybin combined with cognitive‑behavioral counseling helped 40% of smokers remain abstinent for six months, far surpassing the 10% quit rate achieved with standard nicotine patches. The psychedelic group...
Multiple GLP-1 Drugs Linked to Lower AFib Risk
A retrospective analysis of 13,034 patients who started GLP‑1 receptor agonist therapy between 2020 and 2024 found a significant reduction in atrial fibrillation (AFib) incidence compared with a propensity‑matched cohort of over 385,000 untreated individuals. The benefit persisted regardless of...
What Dentistry Is Teaching Healthcare About Operational AI
Artificial intelligence is moving from isolated pilots to core operations across healthcare, but fragmented systems are turning speed into inconsistency. Dentistry, with its tighter reimbursement cycles and integrated workflows, is serving as an early proving ground for operational AI that...
UK Doctors Should Not Speak in the Public Domain of Their Concerns About Political Persons.
A recent BMJ rapid response argues that UK‑registered doctors are prohibited by the General Medical Council’s Good Medical Practice from publicly speculating on the mental health of identifiable political figures. The letter stresses that diagnostic commentary requires a therapeutic relationship,...
With Ultrasound on a Chip, Butterfly Network Aims for Global Reach
Butterfly Network, under CEO Joe DeVivo, is scaling its chip‑based handheld ultrasound priced around $4,000 to make imaging affordable and portable worldwide. The device replaces costly cart‑based machines ($30,000‑$200,000) with a probe containing 9,000 sensors and AI‑enhanced modes, and the...
Cellular Rejuvenation Has the Potential to Reverse Aging
Researchers have identified a natural cellular rejuvenation process that resets embryonic cells to a youthful state within two weeks, effectively erasing parental age markers. Over the past two decades, labs have revived skin cells from 90‑year‑olds and rejuvenated diseased mice,...
Innovator Spotlight: PocDoc
UK health‑tech firm PocDoc, founded in 2020, has secured more than £10 million (≈$12.7 million) in investment to expand its smartphone‑based Healthy Heart Check, a point‑of‑care test that delivers cholesterol, BMI and ten‑year cardiovascular risk in ten minutes. The funding, led by...
FDA Clears Subcutaneous Anifrolumab Autoinjector for Moderate to Severe SLE
The FDA has cleared AstraZeneca’s subcutaneous anifrolumab autoinjector (Saphnelo) for adults with moderate to severe systemic lupus erythematosus (SLE) on standard therapy. The new formulation mirrors the approved intravenous product but allows weekly self‑administration at home. Approval rests on the...
Dignio Investment Signals Remote Care International Expansion
Summa Equity, through its Fund III vehicle, has invested in Norwegian health‑tech firm Dignio to accelerate the company’s remote‑care platform. Dignio provides an integrated digital solution that combines remote patient monitoring, telehealth visits, and automated medication dispensing for home‑based care....
How Recent Changes in ‘Patient-Matched’ Technology Are Reshaping the Future of Surgical Care
Advances in CT, MRI and AI-driven modeling are enabling patient‑matched medical devices that are designed around each individual's anatomy rather than using standard sizes. These bespoke implants and surgical guides improve anatomical concordance, cut intra‑operative adjustments, and can shorten procedure...
WHOOP’s $575 Million Raise Signals the Global Interest in Health Wearables
WHOOP announced a $575 million Series G round that lifts its valuation to $10.1 billion, nearly triple its 2021 level. The capital, led by Collaborative Fund and joined by investors such as Qatar Investment Authority, Mubadala, Abbott and the Mayo Clinic, will fund...
FDA Priority Review Advances Nipocalimab for Adults With Warm Autoimmune Hemolytic Anemia
The FDA has granted priority review to Johnson & Johnson’s nipocalimab‑aahu (IMAAVY) for adults with warm autoimmune hemolytic anemia (wAIHA), a rare disease lacking any approved U.S. therapy. The designation compresses the review clock to roughly six months, marking the...
The New Human Blood Type That Only 3 People on Earth Have—And the Hunt for the 4th
Researchers in Thailand identified a previously unknown human blood type, designated B(A), found in only three individuals. The type results from a four‑gene mutation that produces mostly B antigens with trace A antigens, adding to the 48 known types for...
Wash. Health Department Installs Free 24/7 Narcan Dispenser Outside Firehouse
Grant County Fire District 7 in Soap Lake, Washington installed a free 24/7 Narcan dispenser outside its station, funded by a Grant County Health District grant. The device lets bystanders administer naloxone within minutes, dramatically improving survival odds before firefighters arrive....
You Can’t Close the Minority Health Gap While Ignoring Fathers
National Minority Health Month spotlights chronic disease prevention, yet Black and Brown fathers remain largely invisible in the conversation. Data from the Office of Minority Health reveal that Black men have a life expectancy of 70.3 years—four years below the...
STAT+: Pharmalittle: We’re Reading About a Lilly Deal, an Intellia CRISPR Rare-Disease Treatment, and More
Intellia Therapeutics reported that a single dose of its CRISPR‑based therapy lonvo‑z dramatically reduced swelling attacks in hereditary angioedema patients during a Phase 3 trial, positioning it for a rolling FDA submission as the potential second approved CRISPR drug. The treatment...
FDA Review Sought for Subcutaneous Risankizumab Induction in Crohn Disease
AbbVie has filed a supplemental NDA with the FDA to add subcutaneous (SC) risankizumab induction for adults with moderate‑to‑severe Crohn disease. The request relies on the phase 3 AFFIRM trial, which enrolled 289 patients—65% of whom had failed prior advanced therapies—and...
Practicing Today for Tomorrow’s Emergencies – WHO Convenes Countries and Partners to Simulate Response to Major Disease Outbreak
The World Health Organization concluded Exercise Polaris II, a two‑day high‑level simulation that modeled a fictional bacterial pandemic. The drill brought together 26 countries, 600 health‑emergency experts and more than 25 partner agencies to activate emergency coordination structures, share data and...
VITAS Banks on Length of Stay, Referral Mix Management
VITAS Healthcare eliminated its Medicare cap liability in Florida by shifting admissions toward hospital referrals, which generate shorter stays. In Q1 2026 the company posted $420 million in revenue, a 3.1% year‑over‑year increase, with admissions up 6.9% and average daily census...
FDA Clears Tandem Control-IQ+ for Type 1 Diabetes During Pregnancy: First AID System to Earn Indication
The FDA has cleared Tandem Diabetes Care’s Control‑IQ+ system for use in pregnancies complicated by type 1 diabetes, making it the first automated insulin‑delivery (AID) platform with a pregnancy indication in the United States. The clearance covers both the t:slim X2 pump...
Too Many Prescriptions, Too Many Fatal Falls
U.S. seniors are facing a surge in fatal falls, with 41,000 deaths recorded in 2023, while the proportion taking multiple prescriptions has climbed dramatically. Four in ten older adults now use five or more drugs, and more than 7.5 million are...
Auxira Health and St. Luke’s University Health Network Partner to Expand Virtual Cardiology Support
St. Luke’s University Health Network has teamed with Auxira Health to embed virtual cardiology support teams within its Heart & Vascular network. The pilot launches with 24 cardiologists, each paired with nurse practitioners, medical assistants and registered nurses who handle...
NEJM Catalyst Study Validates No Barrier’s Hybrid AI-Human Model for High-Stakes Surgical Communication
A NEJM Catalyst study at Mass General Brigham independently evaluated No Barrier’s AI‑powered medical interpretation platform alongside remote video interpretation (RVI). The research used a modified technology acceptance model with 23 Spanish‑speaking surgical patients, finding RVI preferred for emotionally sensitive...
The Hidden Costs of Supply Chain Disruptions in Healthcare
Healthcare supply chains are increasingly fragile, with regulatory hurdles, just‑in‑time inventories, and limited visibility exposing hospitals to costly disruptions. The pandemic highlighted that only about 6% of U.S. health systems can see beyond Tier 1 suppliers, leading to frequent shortages. Financial...
CureVac Takes Moderna to Court over mRNA Vaccine Patents
CureVac has filed a lawsuit against Moderna alleging infringement of its mRNA‑stabilisation and delivery patents that underpin Spikevax. The case, backed by BioNTech after its 2025 acquisition of CureVac, seeks a share of the multibillion‑dollar revenues from COVID‑19 mRNA vaccines....
FDA’s Need for Speed Could Strain Small Biotechs. Here’s How They Can Keep Up.
The FDA is accelerating drug approvals through the National Priority Voucher pilot, which can shrink review timelines from ten months to as little as two, and a new plausible mechanism pathway for niche therapies lacking large trial data. While the...
Mark Cuban’s Cost Plus Drugs And Humana In Deal To Take On Employer Drug Costs
Mark Cuban’s Cost Plus Drug Company has partnered with Humana’s CenterWell Pharmacy to create end‑to‑end employer prescription solutions. The deal leverages Cost Plus’s low‑price model and its SwiftyRx digital platform alongside CenterWell’s distribution network and more than 500 pharmacists. While financial terms...
Care Home Manager Struck Off over 'Horrific' Restraining of Disabled Person
A tribunal in Ayrshire stripped care home manager Janette Donnelly of her nursing licence after she forcibly restrained a disabled resident to administer a COVID‑19 vaccine through the resident’s clothing. The panel described the restraint as "horrific" and found Donnelly...
RFK Jr. Vows to End ‘Illusion’ of Lower Premiums Under ACA
U.S. Health and Human Services Secretary Robert F. Kennedy Jr. testified before the House Ways & Means and Education & Workforce committees, arguing that the Affordable Care Act’s subsidy structure creates an illusion of lower premiums while actually benefiting insurers....
Lawmakers Introduce Bipartisan Bill to Speed up Prior Authorization in Medicare Advantage
Congress introduced the bipartisan Medicare Advantage Improvement Act to cut prior‑authorization delays. The bill mandates health plans to complete standard authorizations within 72 hours and publish timing data. It also requires real‑time, EHR‑integrated approval systems and limits extensions to seven...